National Comprehensive Cancer Network

About NCCN

NCCN Announces Global Corporate Council

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

The National Comprehensive Cancer Network® (NCCN®) launched its new Global Corporate Council on March 12, 2015, during its 20th Annual Conference: Advancing the Standard of Cancer Care.

NCCN currently offers membership in NCCN Corporate Council in order to significantly enhance collaborative efforts between pharmaceutical and biotechnology companies and NCCN for activities in the United States.

NCCN Global Corporate Council is intended to provide the same opportunity for dialog, collaboration, and support of NCCN’s work toward achieving its mission and vision outside the United States.

To date, NCCN has commitments from eight companies to support and participate in Global Corporate Council: Astellas; Bayer HealthCare, LLC; Bristol-Myers Squibb; HELSINN; Sanofi Oncology; Seattle Genetics®; Takeda Oncology; and Janssen.

To learn more, visit